GenWay Clinical Laboratory, a US-based diagnostic company with CLIA certification, has validated a general tumor marker test in their laboratory and now offers this testing service. This is an ELISA-based assay which simply requires a small blood sample from the patient in order to quantify the amount of the tumor marker in their serum.
Home » New General Tumor Marker Test Now Available
More recent news
- A new way to monitor glucose: Glucotrack explains 3-year CBGM implant technology
- Dexcom continues advances in AI for CGM, type 2 diabetes awareness
- Tandem continues to deliver more options, benefits for those with diabetes
- Breaking: Sequel to launch twiist automated insulin delivery system next month
- Dexcom shares U.S. report on CGM benefits for type 2 diabetes